Caption Management’s BeOne Medicines Ltd ONC Stock Holding History

Caption Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,700	Closed	-$5.38M	–	2174
2025 Q4	$5.38M	Buy	+17,700	New	+$5.79M	0.04%	500
2025 Q3	–	Sell	-15,000	Closed	-$3.63M	–	2118
2025 Q2	$3.63M	Hold	15,000	–	–	0.04%	509
2025 Q1	$4.08M	Buy	+15,000	New	+$3.51M	0.04%	458
2024 Q1	–	Sell	-7,500	Closed	-$1.35M	–	1739
2023 Q4	$1.35M	Sell	7,500 -6,900	-48%	-$1.25M	0.02%	735
2023 Q3	$2.59M	Buy	+14,400	New	+$2.85M	0.04%	516
2023 Q2	–	Sell	-15,000	Closed	-$3.23M	–	1457
2023 Q1	$3.23M	Sell	15,000 -23,400	-61%	-$5.61M	0.06%	327
2022 Q4	$8.45M	Buy	+38,400	New	+$7.04M	0.13%	191
2022 Q2	–	Sell	-15,000	Closed	-$2.83M	–	1912
2022 Q1	$2.83M	Sell	15,000 -40,800	-73%	-$8.67M	0.03%	632
2021 Q4	$15.1M	Buy	55,800 +20,800	+59%	+$7.02M	0.17%	150
2021 Q3	$12.7M	Buy	35,000 +15,000	+75%	+$4.9M	0.15%	179
2021 Q2	$6.86M	Buy	+20,000	New	+$6.62M	0.09%	289
2020 Q4	–	Sell	-10,500	Closed	-$3.01M	–	1293
2020 Q3	$3.01M	Buy	+10,500	New	+$2.47M	0.07%	322
2020 Q1	–	Sell	-45,100	Closed	-$7.48M	–	1119
2019 Q4	$7.48M	Buy	45,100 +25,000	+124%	+$4.15M	0.25%	95
2019 Q3	$2.46M	Buy	+20,100	New	+$2.67M	0.13%	202

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caption Management's ONC Position: Q1 2026 in Review

Caption Management reduced its BeOne Medicines Ltd (ONC) stake by 56% in Q1 2026, selling an estimated $946K and leaving 2,300 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Caption Management first reported a position in ONC in Q4 2021 and has held it in 7 quarters since. The position peaked at $15.1M in Q4 2022. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Caption Management held 2,300 shares of BeOne Medicines Ltd worth $683K as of Q1 2026.
Caption Management sold 2,924 BeOne Medicines Ltd shares in Q1 2026, an estimated $946K.
BeOne Medicines Ltd made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1124 holding.
Caption Management first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 7 quarters since.
Caption Management's BeOne Medicines Ltd position peaked at $15.1M in Q4 2022.
281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.